OrganiGram Holdings Inc OGI Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.88 down $0.05, 5.72% at close Nov 6
Last close · Previous close $0.93
- Market cap
- $119.63MAt the Nov 6 close
- P/E ratio
- 2.04On last 12 months’ EPS
- Diluted EPS
- $0.43Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.88down $0.09, 9.64%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.93Nov 5
- Volume1.13MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume526.39KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.85 to $2.24; now $0.88
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
OGI trailed the S&P 500 in all 7 periods.
| Period | OGI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OGI: down 9.6% S&P 500: down 5.6% | OGI trailed the S&P 500 by 4.0 percentage points Trailed |
| 3M | OGI: down 11.5% S&P 500: down 4.1% | OGI trailed the S&P 500 by 7.4 percentage points Trailed |
| YTD | OGI: down 47.8% S&P 500: up 8.7% | OGI trailed the S&P 500 by 56.5 percentage points Trailed |
| 1Y | OGI: down 40.8% S&P 500: up 10.9% | OGI trailed the S&P 500 by 51.7 percentage points Trailed |
| Long term | ||
| 3Y | OGI: down 36.5% S&P 500: up 75.0% −14.0% vs +20.5% a year | OGI trailed the S&P 500 by 111.5 percentage points Trailed |
| 5Y | OGI: down 90.4% S&P 500: up 67.8% −37.4% vs +10.9% a year | OGI trailed the S&P 500 by 158.2 percentage points Trailed |
| 10Y | OGI: down 87.9% S&P 500: up 313.1% −19.0% vs +15.2% a year | OGI trailed the S&P 500 by 401.0 percentage points Trailed |
$10,000 invested in OGI 10 years ago (Nov 4, 2016) would be worth about $1,212 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
OGI trailed the S&P 500 in all 7 periods.
| Period | OGI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OGI: down 9.6% S&P 500: down 5.6% | OGI trailed the S&P 500 by 4.0 percentage points Trailed |
| 3M | OGI: down 11.5% S&P 500: down 4.3% | OGI trailed the S&P 500 by 7.2 percentage points Trailed |
| YTD | OGI: down 47.8% S&P 500: up 7.8% | OGI trailed the S&P 500 by 55.6 percentage points Trailed |
| 1Y | OGI: down 40.8% S&P 500: up 9.7% | OGI trailed the S&P 500 by 50.5 percentage points Trailed |
| Long term | ||
| 3Y | OGI: down 36.5% S&P 500: up 68.8% −14.0% vs +19.1% a year | OGI trailed the S&P 500 by 105.3 percentage points Trailed |
| 5Y | OGI: down 90.4% S&P 500: up 56.9% −37.4% vs +9.4% a year | OGI trailed the S&P 500 by 147.3 percentage points Trailed |
| 10Y | OGI: down 87.9% S&P 500: up 252.6% −19.0% vs +13.4% a year | OGI trailed the S&P 500 by 340.5 percentage points Trailed |
$10,000 invested in OGI 10 years ago (Nov 4, 2016) would be worth about $1,212 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$33.40
Closing high on . Now 97.4% below that record.
Split-adjusted daily closes since Aug 27, 2014.
Stock splits
1
1-for-4 on . Share counts adjust after each split.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
2.0×The Nov 6 close ÷ diluted EPS over the last 12 months ($0.43)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
OGI trades at 2.0× its earnings over the last 12 months, below its 5-year median of 13.7×. In plain terms, buyers are paying about $2 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 0.5×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 0.3×Book value as of Jun 30, 2026
Price relative to accounting equity (book value) per share on the Jun 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 1.7×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - −17.91%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $126.26MAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own OGI DCF in Excel. Value OrganiGram Holdings with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $222.22Mup 39.1%
- Net income
- $60.72Mup 1,126.2%
- Diluted EPS
- $0.43
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Sep 30, 2024) | $32.87M | −$3.99M | −$0.07 |
| Q1 FY25 (Dec 31, 2024) | $29.67M | −$15.94M | −$0.14 |
| Q2 FY25 (Mar 31, 2025) | $45.56M | $29.48M | $0.22 |
| Q3 FY25 (Jun 30, 2025) | $51.67M | −$4.59M | −$0.03 |
| Q4 FY25 (Sep 30, 2025) | $58.02M | −$27.51M | −$0.22 |
| Q1 FY26 (Dec 31, 2025) | $46.38M | $14.58M | $0.11 |
| Q2 FY26 (Mar 31, 2026) | $43.33M | −$667.39K | −$0.01 |
| Q3 FY26 (Jun 30, 2026) | $74.49M | $74.32M | $0.54 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Aug 31, 2021) | $63.33M | −$104.56M | Paused See the note under the price. |
| FY22 (Aug 31, 2022) | $112.16M | −$10.99M | Paused See the note under the price. |
| FY23 (Sep 30, 2023) | $119.73M | −$184.15M | −$2.27 |
| FY24 (Sep 30, 2024) | $117.53M | −$33.41M | −$0.35 |
| FY25 (Sep 30, 2025) | $187.81M | −$17.94M | −$0.14 |
Margins
- Gross 36.5%
- Operating −7.9%
- Net 27.3%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$21.42MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$20.67MLast 12 months
- Capital spending$758.35KLast 12 months
- −9.6%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $45.88MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paidNot reportedLast 12 months
Balance sheet
- $22.18MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$14.77MAs of Jun 30, 2026
- Net cash$7.41MAs of Jun 30, 2026
- 2.61As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.04As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 4 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✗Operating cash flow was positive: not passed
- ✓Return on assets improved: passed
- ✗Operating cash flow exceeded net income: not passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 21.4%Last 12 months
Over the last 12 months, OrganiGram Holdings’s net income was 21.4% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 13.9%Last 12 months
Over the last 12 months, OrganiGram Holdings’s net income was 13.9% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About OrganiGram Holdings Inc
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- New Brunswick, Canada
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
OGI news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
OGI stock FAQ
What is OGI stock’s price today?
OrganiGram Holdings (OGI) traded at $0.88 at the close on , down $0.05 (5.72%) from the previous close of $0.93. Over the past 52 weeks it has traded between $0.85 and $2.24.
If you invested $1,000 in OGI 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in OGI on would be worth about $121 at the close on , a total return of −87.9%. The same $1,000 would be worth $96 if invested five years ago and $592 if invested one year ago. Past performance doesn’t predict future returns.
What is OrganiGram Holdings’s market cap?
OrganiGram Holdings’s market capitalization is about $119.6 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.88 (how market cap works). OrganiGram Holdings reported 136.47M shares outstanding at the end of its latest quarter ().
What is OGI’s P/E ratio?
OGI trades at 2.0 times its diluted earnings over the four quarters to ($0.43 per share), at the close. Over the past five years its P/E has ranged from 1.9 to 47.2, with a median of 13.7. (How the P/E ratio works.)
How much revenue does OrganiGram Holdings make?
OrganiGram Holdings reported $222.2 million of revenue over the four quarters to , up 39.1% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $74.5 million, up 44.2% from a year earlier.
Is OrganiGram Holdings profitable?
Yes. OrganiGram Holdings earned $60.7 million of net income over the four quarters to , a net margin of 27.3%, and its operating margin was −7.9% (what margins tell you).
What are OGI’s earnings per share?
OGI’s diluted earnings per share were $0.43 over the four quarters to , compared with −$0.02 in the twelve months before. The latest quarter (Q3 FY26) brought $0.54 per share, against −$0.03 a year earlier (how EPS works).
Does OGI pay a dividend?
OrganiGram Holdings hasn’t paid a dividend in the last twelve months.
What is OGI’s 52-week high and low?
Over the past 52 weeks OGI has traded as low as $0.85 and as high as $2.24. At $0.88 at the close on , it is 60.9% below that high and 2.8% above the low.
What is OGI’s all-time high?
OGI’s highest closing price was $33.40 on , adjusted for stock splits. At $0.88 at the close on , it is 97.4% below that record.
Has OGI stock ever split?
Yes, once: 1-for-4 on .
How has OGI stock performed?
Including dividends and measured to the close on , OGI has returned −47.8% so far this year and −40.8% over the past year, and −90.4% over five years (−37.4% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is OrganiGram Holdings in?
OrganiGram Holdings is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is headquartered in New Brunswick, Canada.
What exchange does OGI trade on?
OrganiGram Holdings trades on the Nasdaq under the ticker symbol OGI. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.